DE60219653D1 - Pharmazeutische zusammensetzung mit chito-oligomeren - Google Patents

Pharmazeutische zusammensetzung mit chito-oligomeren

Info

Publication number
DE60219653D1
DE60219653D1 DE60219653T DE60219653T DE60219653D1 DE 60219653 D1 DE60219653 D1 DE 60219653D1 DE 60219653 T DE60219653 T DE 60219653T DE 60219653 T DE60219653 T DE 60219653T DE 60219653 D1 DE60219653 D1 DE 60219653D1
Authority
DE
Germany
Prior art keywords
oligomers
chito
pharmaceutical composition
treatment
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60219653T
Other languages
English (en)
Other versions
DE60219653T2 (de
Inventor
Jon M Einarsson
Johannes Gislason
Martin Peter
Sven Bahrke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genis ehf
Original Assignee
Genis ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genis ehf filed Critical Genis ehf
Publication of DE60219653D1 publication Critical patent/DE60219653D1/de
Application granted granted Critical
Publication of DE60219653T2 publication Critical patent/DE60219653T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE60219653T 2001-09-26 2002-09-26 Pharmazeutische zusammensetzung mit chito-oligomeren Expired - Lifetime DE60219653T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS608501 2001-09-26
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum
PCT/IS2002/000016 WO2003026677A1 (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers

Publications (2)

Publication Number Publication Date
DE60219653D1 true DE60219653D1 (de) 2007-05-31
DE60219653T2 DE60219653T2 (de) 2008-01-03

Family

ID=36700489

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60219653T Expired - Lifetime DE60219653T2 (de) 2001-09-26 2002-09-26 Pharmazeutische zusammensetzung mit chito-oligomeren

Country Status (13)

Country Link
US (2) US7985741B2 (de)
EP (1) EP1435976B1 (de)
JP (1) JP4613008B2 (de)
KR (1) KR20040062548A (de)
AT (1) ATE359797T1 (de)
CA (1) CA2507926C (de)
DE (1) DE60219653T2 (de)
DK (1) DK1435976T3 (de)
ES (1) ES2284935T3 (de)
IS (2) IS6085A (de)
PT (1) PT1435976E (de)
SI (1) SI1435976T1 (de)
WO (1) WO2003026677A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002351576A1 (en) * 2001-12-13 2003-07-09 Ism Biopolymer Inc. Method of modulating release of saccharides and uses thereof
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
EP1670486A4 (de) * 2003-10-01 2009-04-01 Optimer Pharmaceuticals Inc Behandlung eines zustands in einem säugetier mit verabreichung von aminozucker und verwendungen davon
CN101141968A (zh) * 2003-11-24 2008-03-12 浩鼎生技公司 给予化合物治疗哺乳动物的病况及其应用方法
WO2005112948A1 (ja) * 2004-05-21 2005-12-01 Tottori University 創傷の治療又は処置のための薬剤
EP1917218B1 (de) * 2005-06-14 2017-05-17 Genís hf. Zusammensetzungen aus teil-deacetylierten chitinderivaten
WO2007001283A2 (en) * 2005-06-16 2007-01-04 E.I. Dupont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
US7485718B2 (en) 2005-06-16 2009-02-03 E. I. Du Pont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
KR100831335B1 (ko) * 2006-06-22 2008-05-22 부경대학교 산학협력단 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제
US20110212186A1 (en) * 2008-07-18 2011-09-01 Johannes Gislason Composition for treating autoimmune disorders
KR20100060634A (ko) * 2008-11-28 2010-06-07 (주)아모레퍼시픽 미토콘드리아 활성화를 위한 조성물
KR101729137B1 (ko) * 2009-07-28 2017-04-26 (주)아모레퍼시픽 키토올리고당을 함유하는 피로회복용 조성물
JP6141265B2 (ja) 2011-06-03 2017-06-07 マグワイア アビー， エルエルシー 関節の潤滑性を改善するための方法、組成物及び物品
EP3058826A1 (de) 2011-09-08 2016-08-24 Novozymes BioAG A/S Saatgutbehandlungsverfahren
CN104093680B (zh) 2011-09-14 2016-08-24 诺维信生物农业公司 组合使用脂壳寡糖和/或壳寡糖与解磷微生物促植物生长
AU2012312003B2 (en) * 2011-09-23 2015-10-22 Novozymes Bioag A/S Chitooligosaccharides and methods for use in enhancing plant growth
MX2014003411A (es) * 2011-09-23 2015-03-19 Novozymes Bioag As Quitooligosacaridos y metodos para el uso en el mejoramiento del crecimiento del maiz.
US9474828B2 (en) 2012-04-23 2016-10-25 Genis Hf. Self-hardening bioactive cement compositions with partially deacetylated chitin as bone graft substitutes
JP6285497B2 (ja) * 2016-06-07 2018-02-28 株式会社エバーライフ 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法
KR101673368B1 (ko) 2016-07-14 2016-11-08 김기혁 공정가스 반응물의 콜드트랩 장치
WO2023205718A2 (en) * 2022-04-21 2023-10-26 Hassan Ameer E Methods of treating inflammation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919122B2 (ja) * 1976-10-12 1984-05-02 味の素株式会社 水溶性部分脱アセチル化キチン及びその製造法
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JP2527317B2 (ja) * 1986-12-19 1996-08-21 ライオン株式会社 骨疾患治療剤
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
WO1998025631A1 (en) * 1996-12-13 1998-06-18 Lescarden, Inc. Treatment of osteoarthritis by administering poly-n-acetyl-d-glucosamine
JP3062592B2 (ja) * 1997-05-30 2000-07-10 農林水産省食品総合研究所長 ２−アセチルアミノ−４−Ｏ−（２−アミノ−２−デオキシ−β−Ｄ −グルコピラノシル）−２−デオキシ−Ｄ −グルコースおよびその塩の製造法
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (de) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Verwendung von Chitin-enthaltenden Produkten zur Hemmung von der Erzeugung von NO
CA2313836C (en) * 2000-03-15 2009-06-09 Cargill, Incorporated Chitosan and method of preparing chitosan
US20020119949A1 (en) * 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
EP1917218B1 (de) 2005-06-14 2017-05-17 Genís hf. Zusammensetzungen aus teil-deacetylierten chitinderivaten

Also Published As

Publication number Publication date
US20110257381A1 (en) 2011-10-20
SI1435976T1 (sl) 2007-08-31
DK1435976T3 (da) 2007-08-27
US8415326B2 (en) 2013-04-09
ATE359797T1 (de) 2007-05-15
KR20040062548A (ko) 2004-07-07
IS6085A (is) 2003-03-27
CA2507926C (en) 2011-12-20
ES2284935T3 (es) 2007-11-16
DE60219653T2 (de) 2008-01-03
EP1435976B1 (de) 2007-04-18
EP1435976A1 (de) 2004-07-14
JP4613008B2 (ja) 2011-01-12
CA2507926A1 (en) 2003-04-03
US20050004073A1 (en) 2005-01-06
PT1435976E (pt) 2007-06-28
JP2005507891A (ja) 2005-03-24
US7985741B2 (en) 2011-07-26
IS7193A (is) 2004-03-22
IS2783B (is) 2012-05-15
WO2003026677A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
DE60219653D1 (de) Pharmazeutische zusammensetzung mit chito-oligomeren
EP2085780A3 (de) Verfahren und Produkte die mit niedermolekularem Heparin assoziiert sind
ATE525076T1 (de) Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel
EP2497478A3 (de) Oligosaccarid-Zusammensetzungen und ihre Verwendung bei der Behandlung von Infektionen
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
DE69534759D1 (de) Polyanionische Polysaccharide und hydrophobe, bioabsorbierbare Polymere enthaltende Zusammensetzungen
HK1066482A1 (en) Use os fucans in the treatment of adhesions, arthritis and psoriasis
WO2008015249A3 (en) Cosmetic or pharmaceutical composition containing hyaluronic acid
EP1743906A3 (de) Modifizierte Polysaccharide
BRPI0711620A2 (pt) misturas poliméricas de polissacarídeos aniônicos e catiônicos e uso destas
FR2842201B1 (fr) Nouvel oligosaccharide, compositions cosmetiques et/ou dermatologiques en contenant et ses applications
DE602006008985D1 (de) Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund
JP2006502129A5 (de)
ES2161615A1 (es) Composiciones de heparinas de muy bajo peso molecular.
BR0210139A (pt) Composições farmacêuticas
JP2005507891A5 (de)
WO2004105737A3 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
PL375693A1 (en) Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups
DE602006018058D1 (de) Viskosupplementation mit algen-polysacchariden bei der behandlung von arthritis
DK0960132T3 (da) Polysaccharid, mikroorganisme og fremgangsmåde til fremstilling deraf, præparat med indhold deraf samt anvendelse
NO20010940D0 (no) TAN-1057 derivater
DE60329397D1 (de) Tomatenprodukte
DE60038320D1 (de) Mittel zur bekämpfung von entzündungen und/oder degenerativen erkrankungen
ATE328603T1 (de) Modulatoren von polysacchariden und deren verwendungen
WO2007059874A3 (en) Compositions for the treatment of osteoarthritis and to nourish the synovial fluid

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: EINARSSON, JON M., IS-101 REYKJAVIK, IS

Inventor name: GISLASON, JOHANNES, IS-105 REYKJAVIK, IS

Inventor name: PETER, MARTIN, 14476 GOLM, DE

Inventor name: BAHRKE, SVEN, 14476 GOLM, DE

8364 No opposition during term of opposition